Back to Newsroom

Cyclacel Pharmaceuticals to Release Third Quarter 2017 Financial Results

BERKELEY HEIGHTS, N.J., Nov. 02, 2017 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases, will announce third quarter 2017 financial results on Thursday, November 9, 2017. The Company will host a conference call and live webcast at 4:30 p.m. EST on the same day.